Suppr超能文献

2008 - 2012年中国甲状腺癌的发病率和死亡率

Incidence and mortality of thyroid cancer in China, 20082012.

作者信息

Du Lingbin, Li Runhua, Ge Minghua, Wang Youqing, Li Huizhang, Chen Wanqing, He Jie

机构信息

Zhejiang Cancer Center, Zhejiang Cancer Hospital, Hangzhou 310022, China.

National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Science & Peking Union Medical College, Beijing 100021, China.

出版信息

Chin J Cancer Res. 2019 Feb;31(1):144-151. doi: 10.21147/j.issn.1000-9604.2019.01.09.

Abstract

OBJECTIVE

To analyze the incidence and mortality rates of thyroid cancer (TC) in China from 2008 to 2012.

METHODS

Incident and death cases of TC were retrieved from the National Central Cancer Registry (NCCR) database collecting from 135 cancer registries in China during 2008-2012. The crude incidence and mortality rates of TC were calculated by area (urban/rural), region (eastern, middle, western), gender and age group (0, 1-4, 5-9, …, 85+). China census in 2000 and world Segi's population were applied for age-standardized rates. Joinpoint (Version 4.6.0.0) model was used for time-trend analysis.

RESULTS

The crude incidence rate of TC was 7.56/100,000 which ranked the seventh in overall cancers. The age-standardized incidence rates by China population (ASIRC) and by World population (ASIRW) were 6.25/100,000 and 5.52/100,000, respectively. The crude mortality of TC in China was 0.52/100,000. The age-standardized mortality rates by Chinese standard population (ASMRC) and by world standard population (ASMRW) were 0.34/100,000 and 0.32/100,000, respectively. Incidence and mortality rates of TC were higher in females than in males and higher in urban areas than in rural areas. Eastern areas had the highest incidence followed by middle and western areas. TC incidence increased dramatically after age of 15 years, then peaked at 14.08/100,000 in the group of 50-54 years and finally decreased sharply after 55 years old. TC mortality increased with age in population, reaching the peak of 5.09/100,000 in sub-population aged 85 years or older. TC incidence increased by 4.73 times from 2.40/100,000 in 2003 to 13.75/100,000 in 2012 with an average annual increase of 20%, while TC mortality only increased slightly around 0.32/100,000 from 0.26/100,000 to 0.36/100,000.

CONCLUSIONS

Appropriate targeted prevention, early detection and treatment programs can be carried out to curb the rapid growth trend of TC and control the disease burden.

摘要

目的

分析2008年至2012年中国甲状腺癌(TC)的发病率和死亡率。

方法

从国家癌症中心登记处(NCCR)数据库中检索2008 - 2012年期间中国135个癌症登记处收集的TC发病和死亡病例。按地区(城市/农村)、区域(东部、中部、西部)、性别和年龄组(0、1 - 4、5 - 9、…、85岁及以上)计算TC的粗发病率和死亡率。采用2000年中国人口普查数据和世界Segi人口数据计算年龄标准化率。使用Joinpoint(版本4.6.0.0)模型进行时间趋势分析。

结果

TC的粗发病率为7.56/10万,在所有癌症中排名第七。按中国人口计算的年龄标准化发病率(ASIRC)和按世界人口计算的年龄标准化发病率(ASIRW)分别为6.25/10万和5.52/10万。中国TC的粗死亡率为0.52/10万。按中国标准人口计算的年龄标准化死亡率(ASMRC)和按世界标准人口计算的年龄标准化死亡率(ASMRW)分别为0.34/10万和0.32/10万。TC的发病率和死亡率女性高于男性,城市地区高于农村地区。东部地区发病率最高,其次是中部和西部地区。TC发病率在15岁后急剧上升,然后在50 - 54岁年龄组达到峰值14.08/10万,55岁后急剧下降。TC死亡率随年龄增长而上升,在85岁及以上人群中达到峰值5.09/10万。TC发病率从2003年的2.40/10万增加到2012年的13.75/10万,增长了4.73倍,年均增长20%,而TC死亡率仅从0.26/10万略有增加到0.36/10万左右,约为0.32/10万。

结论

可开展适当的针对性预防、早期检测和治疗项目,以遏制TC的快速增长趋势并控制疾病负担。

相似文献

1
Incidence and mortality of thyroid cancer in China, 20082012.
Chin J Cancer Res. 2019 Feb;31(1):144-151. doi: 10.21147/j.issn.1000-9604.2019.01.09.
2
Incidence and mortality of lung cancer in China, 20082012.
Chin J Cancer Res. 2018 Dec;30(6):580-587. doi: 10.21147/j.issn.1000-9604.2018.06.02.
3
Incidence and mortality of laryngeal cancer in China, 2008-2012.
Chin J Cancer Res. 2018 Jun;30(3):299-306. doi: 10.21147/j.issn.1000-9604.2018.03.02.
4
Incidence and mortality of esophagus cancer in China, 20082012.
Chin J Cancer Res. 2019 Jun;31(3):426-434. doi: 10.21147/j.issn.1000-9604.2019.03.04.
5
National cancer incidence and mortality in China, 2012.
Chin J Cancer Res. 2016 Feb;28(1):1-11. doi: 10.3978/j.issn.1000-9604.2016.02.08.
6
[Incidence and mortality of endometrial cancer in China, data from China Cancer Registry Annual Report, 2004-2017].
Zhonghua Yi Xue Za Zhi. 2024 Mar 12;104(10):721-728. doi: 10.3760/cma.j.cn112137-20231017-00784.
7
Report of incidence and mortality in China cancer registries, 2009.
Chin J Cancer Res. 2013 Feb;25(1):10-21. doi: 10.3978/j.issn.1000-9604.2012.12.04.
8
Incidence and mortality of cervical cancer in China in 2015.
J Natl Cancer Cent. 2022 Feb 3;2(2):70-77. doi: 10.1016/j.jncc.2022.01.002. eCollection 2022 Jun.
9
[Changing trend of incidence and mortality of esophageal cancer during 2010-2016 in Henan Province, China].
Zhonghua Zhong Liu Za Zhi. 2022 Jan 23;44(1):86-92. doi: 10.3760/cma.j.cn112152-20200605-00526.
10
Annual report on status of cancer in China, 2010.
Chin J Cancer Res. 2014 Feb;26(1):48-58. doi: 10.3978/j.issn.1000-9604.2014.01.08.

引用本文的文献

1
Gut microbiome versus thyroid cancer: Association and clinical implications (Review).
Oncol Lett. 2025 May 27;30(1):368. doi: 10.3892/ol.2025.15114. eCollection 2025 Jul.
3
BRAF V600E mutation in thyroid carcinoma: a large-scale study in Han Chinese population.
World J Surg Oncol. 2024 Sep 28;22(1):259. doi: 10.1186/s12957-024-03539-7.
8
GPX4 inhibits apoptosis of thyroid cancer cells through regulating the FKBP8/Bcl-2 axis.
Cancer Biomark. 2024;39(4):349-360. doi: 10.3233/CBM-230220.
9
LRG1 predicts the prognosis and is associated with immune infiltration in thyroid cancer: a bioinformatics study.
Endocr Connect. 2023 Dec 14;13(1). doi: 10.1530/EC-23-0418. Print 2024 Jan 1.
10
Exploring the oral-gut microbiota during thyroid cancer: Factors affecting the thyroid functions and cancer development.
Food Sci Nutr. 2023 Jul 8;11(10):5657-5674. doi: 10.1002/fsn3.3538. eCollection 2023 Oct.

本文引用的文献

1
Incidence and mortality of lung cancer in China, 20082012.
Chin J Cancer Res. 2018 Dec;30(6):580-587. doi: 10.21147/j.issn.1000-9604.2018.06.02.
2
Cancer incidence in Beijing, 2014.
Chin J Cancer Res. 2018 Feb;30(1):13-20. doi: 10.21147/j.issn.1000-9604.2018.01.02.
3
Cancer incidence and mortality in China, 2014.
Chin J Cancer Res. 2018 Feb;30(1):1-12. doi: 10.21147/j.issn.1000-9604.2018.01.01.
4
Psychosocial distress in patients with thyroid cancer.
Otolaryngol Head Neck Surg. 2015 Apr;152(4):644-9. doi: 10.1177/0194599814565761. Epub 2015 Jan 8.
5
The role of surgery in the current management of differentiated thyroid cancer.
Endocrine. 2014 Nov;47(2):380-8. doi: 10.1007/s12020-014-0251-9. Epub 2014 Apr 10.
6
Head and neck cancer: global burden and regional trends in India.
Asian Pac J Cancer Prev. 2014;15(2):537-50. doi: 10.7314/apjcp.2014.15.2.537.
7
Current thyroid cancer trends in the United States.
JAMA Otolaryngol Head Neck Surg. 2014 Apr;140(4):317-22. doi: 10.1001/jamaoto.2014.1.
9
Childhood height and body mass index were associated with risk of adult thyroid cancer in a large cohort study.
Cancer Res. 2014 Jan 1;74(1):235-42. doi: 10.1158/0008-5472.CAN-13-2228. Epub 2013 Nov 18.
10
Thyroid cancer is the most common cancer in women, based on the data from population-based cancer registries, South Korea.
Jpn J Clin Oncol. 2013 Oct;43(10):1039-46. doi: 10.1093/jjco/hyt102. Epub 2013 Jul 25.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验